3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
3
Rectal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Carcinoma, Neuroendocrine
1
Anastomotic Leak
1
Interventions
Cisplatin
4
Etoposide
3
atezolizumab
2
Drug Therapy
2
Carboplatin
2
tivozanib
1
repotrectinib
1
lutetium Lu 177 dotatate
1
durvalumab
1
dostarlimab
1
belinostat
1
Somatostatin
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Ipilimumab
1
FOLFOXIRI protocol
1
EC regimen
1
DLL3 protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Neuroendocrine
×
Somatostatin
×
Clear all
NCT04464122
2025-04-03
REBORN
University of Roma La Sapienza
Recruiting
60 enrolled